Health & Environmental Research Online (HERO)


Print Feedback Export to File
6120628 
Journal Article 
Patch Testing Ingredients of Dermabond and Other Cyanoacrylate-Containing Adhesives 
Cook, KA; White, AA; Shaw, DW 
2019 
Dermatitis: Contact, Atopic, Occupational, Drug
ISSN: 1710-3568
EISSN: 2162-5220 
30 
314-322 
English 
BACKGROUND: Cyanoacrylates are strong adhesives used for a variety of medical, industrial, and cosmetic applications and have been implicated as a cause of allergic contact dermatitis.

OBJECTIVE: The aim of the study was to review our experience in patch testing with cyanoacrylates.

METHODS: We reviewed patch test results of 38 patients with a clinical history of contact dermatitis due to a cyanoacrylate-containing adhesive (mostly Dermabond). Testing used cyanoacrylates of >99% purity diluted to 10% to 30% in petrolatum (pet.), undiluted octyl cyanoacrylate, and/or Dermabond Mini or Advanced "as is." Patch tests were also performed with methacrylates, formaldehyde (a cyanoacrylate impurity), benzalkonium chloride, and cyanoacrylate polymerization inhibitors. Three patients were also tested with Dermabond Mini on abraded skin.

RESULTS: Commercial cyanoacrylate patch testing material (ethyl cyanoacrylate 10% pet.) detected 29% of Dermabond-allergic patients, whereas patch testing with octyl cyanoacrylate 10% pet. increased detection to 50%. Testing with higher concentrations and/or on abraded skin further increased yield. Thirteen (37%) of our 35 cyanoacrylate-allergic patients were also allergic to methacrylates or acrylates.

CONCLUSIONS: Octyl cyanoacrylate is the usual allergenic ingredient in Dermabond. Patch testing with high concentrations is often required. Testing Dermabond on abraded skin further improves diagnostic sensitivity by more closely simulating clinical use. 
IRIS
• Formaldehyde [archived]
     HAWC
          Asthma
               Excluded
          Mechanistic inflammation
               Excluded
     Search Update 2018-2021
          Exposure
               WoS
          Immune Section
               PubMed
          Inflammation/Reactive oxygen Species
               PubMed
• IRIS Formaldehyde (Inhalation) [Final 2024]
     Literature Indexing
          PubMed
          WoS
          2021 Systematic Evidence Map
     Literature Identification
          Immune-Mediated Conditions in Humans, Including Asthma and Allergy
               Excluded
          Inflammation and Immune-Related Mechanistic Studies
               Excluded